Can A Slogan Be A Registered Trademark In Israel?

Published date03 November 2022
Subject MatterIntellectual Property, Patent, Trademark
Law FirmJMB Davis Ben-David Ltd.
AuthorMr Aaron Lewin

A recent decision of the Deputy Registrar of the Israel Patent Office shows how difficult it can be to obtain a trademark registration in Israel for a slogan - even when the slogan has already been registered in a major jurisdiction such as the United Sates.

In application number 328636, filed 14 June 2022, Bristol-Myers Squibb Company requested registration in Israel for the mark, "TRANSFORMING PATIENTS' LIVES THROUGH SCIENCE". The application was filed in Class 44 for the following services: "Providing medical and pharmaceutical information on the topic of health issues and health awareness and pharmaceutical preparations for human use".

The examiner refused the application on the grounds that the mark lacked distinctiveness and was descriptive of the claimed services. The examiner further asserted that the mark was merely a slogan that could not function as a trademark, i.e., as an indicator of origin.

In response, the applicant's attorney argued that the mark was suggestive and not descriptive of the services and in fact does function as a trademark. In the alternative, the applicant's attorney requested acceptance pursuant to Section 16 of the Israel Trademarks Ordinance based upon the prior registration of the mark in the United States. After these arguments were rejected by the examiner, the applicant requested review of the refusal by the Registrar.

A hearing on the case was held in May 2022 before the Deputy Registrar, and on July 31, 2022, the Deputy Registrar issued her decision affirming the examiner's position and finally refusing registration of the mark.

In her decision, the Deputy Registrar noted that a publication of the applicant that was submitted in support of the claim that the mark was distinctive in fact supported the opposite conclusion, that the mark was merely descriptive of the services, in that the publication described the applicant as a pharmaceutical company whose vision and mission was "transforming patients' lives" through the discovery of new medicines. The Deputy Registrar further noted that the combination of words that constituted the mark was not unique to the applicant - other companies in similar or related fields, such as Merck Serono...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT